Atomistry » Zinc » PDB 8qe8-8qrl » 8qng
Atomistry »
  Zinc »
    PDB 8qe8-8qrl »
      8qng »

Zinc in PDB 8qng: Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1)

Protein crystallography data

The structure of Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1), PDB code: 8qng was solved by M.Schimpl, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 47.94 / 2.20
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 55.578, 72.045, 94.786, 90, 90, 90
R / Rfree (%) 21.9 / 29.5

Other elements in 8qng:

The structure of Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1) also contains other interesting chemical elements:

Sodium (Na) 1 atom

Zinc Binding Sites:

The binding sites of Zinc atom in the Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1) (pdb code 8qng). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1), PDB code: 8qng:
Jump to Zinc binding site number: 1; 2;

Zinc binding site 1 out of 2 in 8qng

Go back to Zinc Binding Sites List in 8qng
Zinc binding site 1 out of 2 in the Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1)


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1) within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn502

b:49.6
occ:1.00
SG A:CYS376 2.2 60.8 1.0
SG A:CYS396 2.3 60.9 1.0
SG A:CYS393 2.3 61.9 1.0
SG A:CYS373 2.8 69.2 1.0
CB A:CYS376 3.0 61.4 1.0
CB A:CYS396 3.2 61.6 1.0
CB A:CYS373 3.4 68.2 1.0
N A:CYS376 3.6 63.6 1.0
CB A:CYS393 3.6 63.2 1.0
CA A:CYS376 3.9 61.7 1.0
N A:CYS396 4.1 61.4 1.0
CA A:CYS396 4.2 62.2 1.0
N A:CYS393 4.3 66.2 1.0
CA A:CYS393 4.4 64.4 1.0
OD1 A:ASN379 4.6 62.6 1.0
CB A:ILE375 4.7 66.8 1.0
CB A:ASN379 4.7 58.0 1.0
C A:ILE375 4.7 65.6 1.0
O A:CYS393 4.7 63.5 1.0
CA A:CYS373 4.8 68.3 1.0
C A:CYS376 4.8 60.9 1.0
N A:ALA377 4.8 60.0 1.0
O A:CYS373 4.8 69.5 1.0
C A:CYS393 4.9 63.5 1.0
O A:ASN379 4.9 57.9 1.0
N A:ASN379 5.0 57.6 1.0

Zinc binding site 2 out of 2 in 8qng

Go back to Zinc Binding Sites List in 8qng
Zinc binding site 2 out of 2 in the Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1)


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 2 of Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1) within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn503

b:122.0
occ:1.00
SG A:CYS408 2.3 107.7 1.0
CB A:HIS390 2.6 84.8 1.0
SG A:CYS411 2.7 116.7 1.0
CB A:CYS388 2.8 86.6 1.0
CB A:CYS408 3.2 105.2 1.0
CG A:HIS390 3.5 88.4 1.0
ND1 A:HIS390 3.5 90.7 1.0
SG A:CYS388 3.5 93.4 1.0
N A:HIS390 3.6 82.7 1.0
CA A:HIS390 3.6 82.8 1.0
CA A:CYS388 4.1 85.1 1.0
C A:CYS388 4.3 84.9 1.0
CB A:CYS411 4.3 112.0 1.0
N A:CYS411 4.5 109.7 1.0
O A:HIS390 4.5 81.5 1.0
C A:HIS390 4.6 80.9 1.0
N A:GLY389 4.6 84.3 1.0
O A:CYS388 4.6 85.0 1.0
CA A:CYS408 4.7 105.1 1.0
CE1 A:HIS390 4.8 91.4 1.0
CD2 A:HIS390 4.8 89.9 1.0
C A:GLY389 4.8 83.3 1.0
CD2 A:PHE410 4.8 109.9 1.0
CB A:PHE410 4.8 108.7 1.0
CB A:CYS413 4.9 110.3 1.0
CA A:CYS411 5.0 110.6 1.0

Reference:

M.Schimpl, M.Schimpl. N/A N/A.
Page generated: Thu Oct 31 10:11:11 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy